World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston

Nucleai at World CDx 2026

Oct 5–8, 2026 Boston, MA ~900 attendees Website

Nucleai takes part in 1 session at World CDx 2026 in Boston. Its program centers on AI-powered computational pathology. With Pfizer, Gilead Sciences and Bristol Myers Squibb, it looks at clinical biomarkers that go beyond standard immunohistochemistry scoring.

OrganizationWorld CDx 2026 Attendance
Nucleai
Tel Aviv, Israel
◇Program Partner
nucleai.ai
Software, data & AIProgram Partner
AI pathology and spatial biology company giving drug developers tissue-based insights for biomarker and patient selection strategies, including for ADCs.
Panel
Wed Oct 7
2:10pm
Beyond IHC Scoring: Unlocking Next-Generation Clinical Biomarkers through AI-Powered Computational Pathology
with Pfizer, Gilead Sciences, Bristol Myers Squibb +1 more
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine

Explore the full World CDx 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full World CDx 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Nucleai

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World CDx or its organizers. Submit a correction